{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:01:00Z","timestamp":1781265660877,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jaip.2025.11.015","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:02:24Z","timestamp":1763766144000},"page":"656-665.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and Activity"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9196-706X","authenticated-orcid":false,"given":"Lianne","family":"ten Have","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin B.","family":"Fieten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur.L.","family":"Meulmeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els J.M.","family":"Weersink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter-Paul","family":"Hekking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"van Nederveen-Bendien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoud F.","family":"Aldenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelis W.","family":"Patberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjo J.T.","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilonka H.","family":"van Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"van Huisstede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Beukert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Macken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen T.M.","family":"Oud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Conemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"van Velzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Amelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen M.A.M.","family":"Retera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"van Ruitenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert-Jan","family":"Braunstahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Kroes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob K.","family":"Sont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"ten Brinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.11.015_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00765-2017","article-title":"\u201cI have lost in every facet of my life\u201d: the hidden burden of severe asthma","volume":"50","author":"Foster","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.11.015_bib2","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1183\/20734735.0165-2019","article-title":"Living well with severe asthma","volume":"15","author":"Stubbs","year":"2019","journal-title":"Breathe"},{"key":"10.1016\/j.jaip.2025.11.015_bib3","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.11.015_bib4","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.11.015_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jaip.2025.11.015_bib6","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.11.015_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/all.15456","article-title":"Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma","volume":"78","author":"Papi","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.11.015_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/biomedicines12020390","article-title":"Dupilumab efficacy on asthma functional, inflammatory, and patient-reported outcomes across different disease phenotypes and severity: a real-life perspective","volume":"12","author":"Caminati","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaip.2025.11.015_bib9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/cea.13614","article-title":"Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohort","volume":"50","author":"Dupin","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.11.015_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.107058","article-title":"Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: a real-world Dutch cohort study","volume":"206","author":"Thelen","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2025.11.015_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02305-2022","article-title":"Moving towards patient-centred outcomes: the Severe Asthma Questionnaire","volume":"61","author":"Davies","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.11.015_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12955-024-02321-3","article-title":"Clinical importance of patient-reported outcome measures in severe asthma: results from U-BIOPRED","volume":"22","author":"Meys","year":"2024","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jaip.2025.11.015_bib13","doi-asserted-by":"crossref","first-page":"00717","DOI":"10.1183\/23120541.00717-2022","article-title":"What bothers severe asthma patients most? A paired patient-clinician study across seven European countries","volume":"9","author":"Ainsworth","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.11.015_bib14","doi-asserted-by":"crossref","first-page":"00497","DOI":"10.1183\/23120541.00497-2020","article-title":"What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance","volume":"7","author":"Clark","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.11.015_bib15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jaip.2021.11.035","article-title":"\u201cNothing about us without us\u201d\u2014what matters to patients with severe asthma?","volume":"10","author":"McDonald","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.015_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.anai.2018.08.005","article-title":"Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma","volume":"122","author":"Corren","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.11.015_bib17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaip.2022.11.044","article-title":"Dupilumab efficacy in patients with uncontrolled or oral corticosteroid-dependent allergic and nonallergic asthma","volume":"11","author":"Brusselle","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.015_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/JAA.S312123","article-title":"Real-world experience with dupilumab in severe asthma: one-year data from an Italian named patient program","volume":"14","author":"Campisi","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2025.11.015_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.anai.2022.12.002","article-title":"The long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma","volume":"130","author":"Sher","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.11.015_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.11.015_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0022-3999(94)90099-X","article-title":"Dimensional assessment of chronic fatigue syndrome","volume":"38","author":"Vercoulen","year":"1994","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jaip.2025.11.015_bib22","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1378\/chest.115.5.1265","article-title":"Validation of a standardized version of the Asthma Quality of Life Questionnaire","volume":"115","author":"Juniper","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.11.015_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaip.2025.11.015_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpsychores.2017.05.007","article-title":"The assessment of fatigue: psychometric qualities and norms for the Checklist individual strength","volume":"98","author":"Worm-Smeitink","year":"2017","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jaip.2025.11.015_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pec.2010.08.021","article-title":"Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status","volume":"85","author":"Peters","year":"2011","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jaip.2025.11.015_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s40744-019-0155-5","article-title":"A threshold of meaning for work disability improvement in psoriatic arthritis measured by the Work Productivity and Activity Impairment Questionnaire","volume":"6","author":"Tillett","year":"2019","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jaip.2025.11.015_bib27","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.11.015_bib28","series-title":"R: A Language and Environment for Statistical Computing","year":"2023"},{"key":"10.1016\/j.jaip.2025.11.015_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v082.i13","article-title":"lmerTest Package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jaip.2025.11.015_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v048.i02","article-title":"lavaan: An R package for structural equation modeling","volume":"48","author":"Rosseel","year":"2012","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jaip.2025.11.015_bib30","series-title":"lavaan: Latent Variable Analysis","author":"Rosseel","year":"2025"},{"key":"10.1016\/j.jaip.2025.11.015_bib32","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.jaip.2025.11.015_bib33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.32614\/RJ-2021-053","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R J"},{"key":"10.1016\/j.jaip.2025.11.015_bib34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1164\/rccm.202405-0894ED","article-title":"Remission in the world of severe asthma","volume":"210","author":"Pavord","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.11.015_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100934","article-title":"Comparative efficacy of biologics for patients with inadequately controlled asthma: a network meta-analysis","volume":"17","author":"Kim","year":"2024","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2025.11.015_bib36","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1111\/all.16178","article-title":"Real-world biologics response and super-response in the International Severe Asthma Registry cohort","volume":"79","author":"Denton","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.11.015_bib37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.alit.2024.02.002","article-title":"Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: a prospective, observational study","volume":"73","author":"Tajiri","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2025.11.015_bib38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2147\/JAA.S403286","article-title":"Real-world experience on the use of mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)","volume":"16","author":"Korn","year":"2023","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2025.11.015_bib39","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00374-2024","article-title":"Anti-interleukin-5\/anti-interleukin-5 receptor alpha treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial","volume":"10","author":"Brinkmann","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.11.015_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12995-024-00406-9","article-title":"Quality of life and work functionality in severe asthma patients: the impact of biological therapies","volume":"19","author":"Leso","year":"2024","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.jaip.2025.11.015_bib41","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1080\/02770903.2023.2196563","article-title":"Anti-IL-5\/5Ra biologics improve work productivity and activity in severe asthma: a RAPSODI registry-based cohort study","volume":"60","author":"van der Valk","year":"2023","journal-title":"J Asthma"},{"key":"10.1016\/j.jaip.2025.11.015_bib42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/jpm14050468","article-title":"The impact of dupilumab on work productivity and emotional health in CRSwNP: a multicentric study in Northeast Italy","volume":"14","author":"Ottaviano","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.jaip.2025.11.015_bib43","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/j.jaip.2024.08.050","article-title":"Severe fatigue in uncontrolled asthma: contributing factors and impact of rehabilitation","volume":"12","author":"Fieten","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.11.015_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12955-023-02155-5","article-title":"Response rates in clinical quality registries and databases that collect patient reported outcome measures: a scoping review","volume":"21","author":"Ruseckaite","year":"2023","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jaip.2025.11.015_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00618-2018","article-title":"The construction and validation of the Severe Asthma Questionnaire","volume":"52","author":"Hyland","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.11.015_bib46","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00606-2022","article-title":"Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)","volume":"61","author":"Khaleva","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.11.015_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41533-019-0149-3","article-title":"A systematic review of psychological, physical health factors, and quality of life in adult asthma","volume":"29","author":"Stanescu","year":"2019","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaip.2025.11.015_bibE1","series-title":"lavaan: Latent Variable Analysis","author":"Rosseel","year":"2025"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825011134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825011134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:51:48Z","timestamp":1781265108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825011134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213219825011134"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.11.015","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and Activity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}